Topics

Latest "Sobi invests 915m Dova hematology portfolio" News Stories

10:01 EST 6th December 2019 | BioPortfolio

Here are the most relevant search results for "Sobi invests 915m Dova hematology portfolio" found in our extensive news archives from over 250 global news sources.

More Information about Sobi invests 915m Dova hematology portfolio on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Sobi invests 915m Dova hematology portfolio for you to read. Along with our medical data and news we also list Sobi invests 915m Dova hematology portfolio Clinical Trials, which are updated daily. BioPortfolio also has a large database of Sobi invests 915m Dova hematology portfolio Companies for you to search.

Showing "Sobi invests 915m Dova hematology portfolio" News Articles 1–25 of 4,600+

Friday 6th December 2019

MJH Life Sciences™ Defeats Engage Healthcare Communications Lawsuit

MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, has conclusively defeated trademark infringement claims brought against 16 of its brands associated with online and print media, conferences and continuing medical education programs. Competing publisher Engag...


Helius Medical Technologies Inc HSM Product Pipeline Analysis, 2019 Update [Published by Global Data] Prices from USD $660

SummaryHelius Medical Technologies Inc HMT is a medical device company that provides neurological wellness solutions. The company provides development, licensing and acquisition of noninvasive platform technologies for amplifying the brain's ability to heal itself. It provides development of technologies as a potential treatment for neurological symptoms caused by disease or trauma. HMT provides P...

Female Sexual Dysfunction Pipeline Drugs and Companies, Q2 2019 [Report Updated: 08042019] Prices from USD $1583

Summary Female Sexual Dysfunction pipeline research report is a part of our 300+ Pharmaceutical and Healthcare disease pipeline report series. It provides detailed insights into Female Sexual Dysfunction RD activities including pipeline candidates, grants, developments, investments, technological advancements, and progress.Extensive Coverage of Pipeline CandidatesThe Female Sexual Dysfunction repo...


Talaris Therapeutics to Present at American Society of Hematology (ASH) Annual Meeting

Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients, announced that founder

Alexion Issues Statement on Path to Value Creation

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today issued the following statement on behalf of the Board of Directors and management team: "The Board and management team are focused on delivering long-term shareholder value by advancing our mission of developing and delivering transformative medicines for people with rare diseases. As part of this commitment, we maintain an active dialogue wit...

Sangamo to Highlight Genomic Medicine Pipeline, Technology Platforms, and Manufacturing Capabilities in December 17 R&D Day

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the Company plans to host an R&D Day on December 17, 2019 at 8am Eastern Time in New York City. Sangamo executives and scientists will provide updates across the Company’s clinical and preclinical pipeline of genomic medicine product candidates, offer perspective on clinical data being presented at t...

Acceleron Appoints Global Innovation and Drug Development Executive Kemal Malik, MB BS, to its Board of Directors

Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced today the appointment of Kemal Malik, MB BS, to its Board of Directors. Dr. Malik, who is currently a member of the Board of Management of Bayer AG, will officially join the Acceleron Board effective January 1,...

Dental Lasers Device Pipeline Study Analysis of Devices under Development, Companies, Developments and Outlook [Published by VPA Research] Prices from USD $1583

Global Dental Lasers market is one of the largely focused segments of medical devices worldwide. The global Dental Lasers industry is estimated to be around $0.2 billion in 2019 driven by increasing demand for advanced dental treatments.Photonics is currently the only company operating Dental Lasers pipeline. It has two products one each in preclinical and clinical phases respectively. Global Dent...

CNN's 'Vital Signs with Dr. Sanjay Gupta' explores Traditional Chinese Medicine in Hong Kong

HONG KONG, Dec. 6, 2019 /PRNewswire/ -- There are few places in the world where modern and traditional intersect quite like Hong Kong, so what better place to explore the world of Traditional Chinese Medicine and ancient lifestyle practices. This month on CNN's 'Vital Signs' Dr. Sanjay Gupta travels to Hong Kong to experience Traditional Chinese Medicine first-hand and explore how it fits into tod...

TransMed7 LLC Product Pipeline Analysis, 2019 Update [Published by Global Data] Prices from USD $660

SummaryTransMed7 LLC TransMed7 is a medical technology company that develops and manufactures biopsy devices. The company offers handheld soft tissue biopsy, stereotactic soft tissue biopsy, fine needle biopsy, vascular intervention, excisional soft tissue biopsy, prostate soft tissue biopsy, endoscopic soft tissue biopsy, robotic soft tissue biopsy, bone marrow biopsy, and laparoscopic biopsy. It...

Angle Biosciences Inc Product Pipeline Analysis, 2019 Update [Published by Global Data] Prices from USD $660

SummaryAngle Biosciences Inc Angle Biosciences, formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flowthru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and applications support, onsite and inhouse training, extended warranty, service and maintena...

Welch Allyn Inc Strategic SWOT Analysis Review [Report Updated: 18042019] Prices from USD $110

Welch Allyn Inc Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business by ...

Medical Lasers and Surgical Lasers Device Pipeline Study Analysis of Devices under Development, Companies, Developments and Outlook [Published by VPA Research] Prices from USD $1583

Global Medical Lasers and Surgical Lasers market is one of the largely focused segments of medical devices worldwide. The global Medical Lasers and Surgical Lasers industry is estimated to be around $7 billion in 2019.The 2019 Medical Lasers and Surgical Lasers pipeline is characterized by presence of 5 companies, actively assessing their devices. In particular, 2 companies are assessing their pro...

Thursday 5th December 2019

Abiomed Inc ABMD Product Pipeline Analysis, 2019 Update [Published by Global Data] Prices from USD $660

SummaryAbiomed Inc Abiomed provides mechanical circulatory support devices and develops, manufactures and markets novel technologies that replace or assist the pumping function in a failing heart. The company's heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheterbased devices includ...

NuVascular Technologies Inc Product Pipeline Analysis, 2018 Update [Report Updated: 27122018] Prices from USD $660

SummaryNuVascular Technologies Inc NuVascular Technologies is a developer of medical devices for the treatment of patients suffering from endstage renal diseases. The company offers hemodialysis access grafts, arteriovenous suture, central venous catheter cuffs, drugeluting vessel wrap, drugeluting stent sheath, and drugeluting balloon. It also develops patented nanotechnology for specific medical...

Short Bowel Syndrome Pipeline Drugs and Companies, Q2 2019 [Report Updated: 08042019] Prices from USD $1583

Summary Short Bowel Syndrome pipeline research report is a part of our 300+ Pharmaceutical and Healthcare disease pipeline report series. It provides detailed insights into Short Bowel Syndrome RD activities including pipeline candidates, grants, developments, investments, technological advancements, and progress.Extensive Coverage of Pipeline CandidatesThe Short Bowel Syndrome report covers all t...

Toll Like Receptor 4 Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $3080

Toll Like Receptor 4 Pipeline Review, H2 2019SummaryToll Like Receptor 4 hToll or CD284 or TLR4 Tolllike receptor 4 is a protein encoded by the TLR4 gene. This receptor is mostly expressed in placenta, and in myelomonocytic subpopulation of the leukocytes. It is involved in LPSindependent inflammatory responses triggered by free fatty acids, such as palmitate, and Ni2+. It responses are triggere...

AXT adds Alvéole's cell biology platform to its portfolio

Scientific equipment supplier AXT has announced the addition of Alvéole’s bioengineering platform for cell biology to its product portfolio. The Alvéole platform allows users to convert an existing microscope into an automated bioengineering system for the engineering of smart cell culture substrates. Alvéole is a French-based manufacturer specialising in designing tools for engineering more...

Kymab Presents Updates at the American Society of Hematology (ASH) 61st Annual Meeting and Exposition

Kymab Presents Updates at the American Society of Hematology (ASH) 61st Annual Meeting and Exposition Cambridge, UK; December 6, 2019: Kymab, a clinical-stage biopharmaceutical company developing monoclonal and bispecific antibody-based therapeutics, today announced that abstracts describing two lead hematology programs, KY1049 and KY1066, will be presented at the American Society of Hemat...

TG Therapeutics Recaps Schedule of Triple Therapy Data Presentations at the Upcoming 61st American Society of Hematology Annual Meeting and Exposition

NEW YORK, Dec. 06, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today recapped the schedule of triple therapy data presentations, at the upcoming 61st American Society of Hematology (ASH) annual meeting and exposition, to be held December 7 – 10, 2019, at the Orange County Convention Center in Orlando, FL. Presentations at the ASH 2019 meeting include the followin...

Proliferative Diabetic Retinopathy PDR Pipeline Drugs and Companies, Q2 2019 [Report Updated: 08042019] Prices from USD $1583

Summary Proliferative Diabetic Retinopathy PDR pipeline research report is a part of our 300+ Pharmaceutical and Healthcare disease pipeline report series. It provides detailed insights into Proliferative Diabetic Retinopathy PDR RD activities including pipeline candidates, grants, developments, investments, technological advancements, and progress.Extensive Coverage of Pipeline CandidatesThe Prol...

Medical Imaging Information Systems Device Pipeline Study Analysis of Devices under Development, Companies, Developments and Outlook [Published by VPA Research] Prices from USD $1583

Global Medical Imaging Information Systems market is one of the largely focused segments of medical devices worldwide. The global Medical Imaging Information Systems industry is estimated to be around $0.8 billion in 2019.The 2019 Medical Imaging Information Systems pipeline is characterized by presence of 24 companies, actively assessing their devices. In particular, 5 companies are assessing the...

NuMed Plus Inc NUMD Product Pipeline Analysis, 2019 Update [Published by Global Data] Prices from USD $660

SummaryNuMed Plus Inc NuMed Plus is a medical device company. The company offers medical products that deliver therapeutic doses of nitric oxide gas to patients. It provides nitric oxide gas delivery system, portable nitric oxide delivery system and nitric oxide dilution system. NuMed Plus' nitric oxide is used for malaria, congenital pulmonary hypoplasia and neonatal hypoxia therapy. The company'...

The Impact of Telemedicine and Access to Leukemia Experts: Insights on Patient Behaviors to be Presented at the American Society of Hematology 61st Annual Meeting

Results from the Expert Access program, jointly pioneered by the nonprofit CLL Society and technology partner InfiniteMD, cover a nearly two year period The Expert Access program for chronic lymphocytic leukemia (CLL), a first-of-its-k

LifeAssay Diagnostics Pty Ltd Product Pipeline Analysis, 2018 Update [Report Updated: 27122018] Prices from USD $660

SummaryLifeAssay Diagnostics Pty Ltd LifeAssay is a medical device manufacturer. The company offers urine analysis, urine adulteration tests, lifestyle tests, lateral flow tests and industrial tests. It manufactures noninvasive semiquantitative dipstick tests intended to measure selective physiological parameters in individuals occupied in weight loss, sport and training programmes. LifeAssay's la...


Quick Search

News Quicklinks